Finance

Stocks making the biggest moves after hours: DoorDash, Applied Materials, DraftKings and more

Products You May Like

In this article

  • TXRH
  • MRNA
  • AMAT
  • DKNG
  • DASH
Rafael Henrique | LightRocket | Getty Images

Check out the companies making headlines in midday trading.

DoorDash — The online food delivery platform’s shares jumped 7% after it reported a revenue beat and upbeat guidance. The company’s fourth-quarter revenue came in at $1.82 billion, topping the $1.77 billion estimated by analysts polled by Refinitiv. Reported losses, however, were greater than analysts’ projections, coming in at a per-share loss of $1.65 versus analysts’ estimates of 68 cents.

related investing news

Pro Picks: Watch all of Wednesday's big stock calls on CNBC

CNBC Pro
Pro Picks: Watch all of Wednesday’s big stock calls on CNBC

Texas Roadhouse — The restaurant chain’s shares dropped about 5%, coming down from a 52-week high during Thursday’s trading session. Texas Roadhouse’s fourth-quarter earnings and revenue fell below expectations. The restaurant posted 89 cents earnings per share versus the $1.03 estimated by analysts polled by Refinitiv. Revenue came in at $1.01 billion, missing analysts’ estimates of $1.02 billion. The company blamed commodity inflation and higher wages for the shortfall.

DraftKings — The sports betting company’s shares gained 6% after its fourth-quarter earnings and revenue exceeded analysts’ estimates. DraftKings posted a per-share loss of 53 cents and revenue of $855 million. Analysts polled by Refinitiv had anticipated a loss of 53 cents per share and $800 million in revenue.

Applied Materials — The semiconductor company’s stock added about 2% after Applied Materials posted its latest results. The company earned $2.03 per share, excluding items, in the first fiscal quarter, topping a consensus estimate of $1.93 per share, according to Refinitiv. Revenue was $6.74 billion in the same quarter, beating analysts’ estimates of $6.69 billion. Meanwhile, the company lowered its guidance for the second fiscal quarter, citing ongoing supply chain challenges.

Moderna — Shares for the biotech company fell 6.7% after its influenza vaccine candidate posted mixed results in clinical trials.

Products You May Like

Articles You May Like

Parents are not confident they can teach kids about investing. Here’s how advisors say to get started
GM’s newest EV is a Cadillac ‘baby Escalade’ called Vistiq
David Einhorn to speak as the priciest market in decades gets even pricier postelection
Three Mile Island restart could mark a turning point for nuclear energy as Big Tech influence on power industry grows
Megacap tech stocks make some room — here is where investors are branching out